SpringerLink
Log in

Atrial Fibrillation Ablation: Indications and Techniques

  • Arrhythmia (R Kabra, Section Editor)
  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Abstract

Purpose of review

Atrial fibrillation (AF) predisposes to embolic strokes and reduced quality of life. Ablation (catheter-based or surgically performed) can be employed to promote the maintenance of sinus rhythm in a carefully selected subset of patients with AF. The goal of this review is to discuss the indications and techniques for AF ablation, as well as post-procedural outcomes.

Recent findings

Atrial fibrillation ablation improves quality of life in patients with atrial fibrillation although no clear reduction in stroke or overall mortality has been shown.

Summary

Familiarity with the indications for AF ablation is important for all cardiologists, as is having a sound understanding of the efficacy of the procedure and potential complications. Furthermore, acquiring a grasp of the different modalities of AF ablation (including percutaneous endocardial techniques and surgical ablation approaches) will help to facilitate effective and appropriate referrals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129:837–47.

    PubMed  Google Scholar 

  2. Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112:1142–7.

    PubMed  Google Scholar 

  3. Calkins H, Reynolds MR, Spector P, Sondhi M, Xu Y, Martin A, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation. Circ Arrhythm Electrophysiol. 2009;2:349–61.

    CAS  PubMed  Google Scholar 

  4. Kuck K-H, Brugada J, Fürnkranz A, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374:2235–45.

    PubMed  Google Scholar 

  5. Wilber DJ, Pappone C, Neuzil P, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation. JAMA. 2010;303:333.

    CAS  PubMed  Google Scholar 

  6. • Packer DL, Mark DB, Robb RA, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation. JAMA. 2019;321:1261 Recent large randomized clinical trail that did not show a mortality benefit with catheter ablation in patients with symptomatic AF. However, catheter ablation did significantly reduce AF recurrence and improve quality of life.

    CAS  PubMed  Google Scholar 

  7. Graves KG, Jacobs V, May HT, Cutler MJ, Day JD, Bunch TJ. Atrial fibrillation ablation and its impact on stroke. Curr Treat Options Cardiovasc Med. 2018;20:2.

    PubMed  Google Scholar 

  8. Bunch TJ, May HT, Bair TL, Crandall BG, Cutler MJ, Day JD, et al. Five-year impact of catheter ablation for atrial fibrillation in patients with a prior history of stroke. J Cardiovasc Electrophysiol. 2018;29:221–6.

    PubMed  Google Scholar 

  9. Barra S, Baran J, Narayanan K, et al. Association of catheter ablation for atrial fibrillation with mortality and stroke: a systematic review and meta-analysis. Int J Cardiol. 2018;266:136–42.

    PubMed  Google Scholar 

  10. Mark DB, Anstrom KJ, Sheng S, et al. Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation. JAMA. 2019;321:1275.

    PubMed  Google Scholar 

  11. Blomström-Lundqvist C, Gizurarson S, Schwieler J, et al. Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation. JAMA. 2019;321:1059.

    PubMed  Google Scholar 

  12. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. Circulation. 2019. https://doi.org/10.1161/CIR.0000000000000665.

  13. • Marrouche NF, Brachmann J, Andresen D, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378:417–27 Small randomized clinical trial which showed a mortality benefit in patients with heart failure and AF who underwent catheter ablation. First randomized clinical trial to show this benefit.

    PubMed  Google Scholar 

  14. Fink T, Rexha E, Schlüter M, et al. Positive impact of pulmonary vein isolation on biventricular pacing in nonresponders to cardiac resynchronization therapy. Heart Rhythm. 2019;16:416–23.

    PubMed  Google Scholar 

  15. Cheng DCH, Ad N, Martin J, Berglin EE, Chang B-C, Doukas G, et al. Surgical ablation for atrial fibrillation in cardiac surgery. Innov Technol Tech Cardiothorac Vasc Surg. 2010;5:84–96.

    Google Scholar 

  16. Badhwar V, Rankin JS, Ad N, et al. Surgical ablation of atrial fibrillation in the United States: trends and propensity matched outcomes. Ann Thorac Surg. 2017;104:493–500.

    PubMed  Google Scholar 

  17. Ad N, Damiano RJ, Badhwar V, Calkins H, La Meir M, Nitta T, et al. Expert consensus guidelines: examining surgical ablation for atrial fibrillation. J Thorac Cardiovasc Surg. 2017;153:1330–1354.e1.

    PubMed  Google Scholar 

  18. Zipes DP, Jalife J, Stevenson WG, William G Cardiac electrophysiology: from cell to bedside

  19. Haines DE. The biophysics of radiofrequency catheter ablation in the heart: the importance of temperature monitoring. Pacing Clin Electrophysiol. 1993;16:586–91.

    CAS  PubMed  Google Scholar 

  20. Arentz T, Weber R, Bürkle G, Herrera C, Blum T, Stockinger J, et al. Small or large isolation areas around the pulmonary veins for the treatment of atrial fibrillation? Circulation. 2007;115:3057–63.

    PubMed  Google Scholar 

  21. Oral H, Scharf C, Chugh A, Hall B, Cheung P, Good E, et al. Catheter ablation for paroxysmal atrial fibrillation. Circulation. 2003;108:2355–60.

    PubMed  Google Scholar 

  22. Haïssaguerre M, Jaïs P, Shah DC, Garrigue S, Takahashi A, Lavergne T, et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation. 2000;101:1409–17.

    PubMed  Google Scholar 

  23. Mantovan R, Macle L, De Martino G, et al. Relationship of quality of life with procedural success of atrial fibrillation (AF) ablation and postablation AF burden: substudy of the STAR AF randomized trial. Can J Cardiol. 2013;29:1211–7.

    PubMed  Google Scholar 

  24. Kochhäuser S, Jiang C-Y, Betts TR, et al. Impact of acute atrial fibrillation termination and prolongation of atrial fibrillation cycle length on the outcome of ablation of persistent atrial fibrillation: a substudy of the STAR AF II trial. Heart Rhythm. 2017;14:476–83.

    PubMed  Google Scholar 

  25. Sau A, Al-Aidarous S, Howard J, et al. Optimum lesion set and predictors of outcome in persistent atrial fibrillation ablation: a meta-regression analysis. Europace. 2019. https://doi.org/10.1093/europace/euz108.

    Google Scholar 

  26. Tse H-F, Lee KLF, Fan K, Lau C-P. Nonfluoroscopic magnetic electroanatomic map** to facilitate focal pulmonary veins ablation for paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2002;25:57–61.

    PubMed  Google Scholar 

  27. Pappone C, Oreto G, Lamberti F, et al. Catheter ablation of paroxysmal atrial fibrillation using a 3D map** system. Circulation. 1999;100:1203–8.

    CAS  PubMed  Google Scholar 

  28. Jaïs P, Haïssaguerre M, Shah DC, Takahashi A, Hocini M, Lavergne T, et al. Successful irrigated-tip catheter ablation of atrial flutter resistant to conventional radiofrequency ablation. Circulation. 1998;98:835–8.

    PubMed  Google Scholar 

  29. Kobza R, Hindricks G, Tanner H, Schirdewahn P, Dorszewski A, Piorkowski C, et al. Late recurrent arrhythmias after ablation of atrial fibrillation: incidence, mechanisms, and treatment. Heart Rhythm. 2004;1:676–83.

    PubMed  Google Scholar 

  30. Macle L, Jaïs P, Weerasooriya R, Hocini M, Shah DC, Choi K-J, et al. Irrigated-tip catheter ablation of pulmonary veins for treatment of atrial fibrillation. J Cardiovasc Electrophysiol. 2002;13:1067–73.

    PubMed  Google Scholar 

  31. Natale A, Reddy VY, Monir G, et al. Paroxysmal AF catheter ablation with a contact force sensing catheter. J Am Coll Cardiol. 2014;64:647–56.

    PubMed  Google Scholar 

  32. Reddy VY, Dukkipati SR, Neuzil P, et al. Randomized, controlled trial of the safety and effectiveness of a contact force–sensing irrigated catheter for ablation of paroxysmal atrial fibrillation. Circulation. 2015;132:907–15.

    PubMed  Google Scholar 

  33. •• Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2018;20:157–208 Recent guidelines on both catheter and surgical ablation of AF. Summarizes relevant research and literature related to AF ablation.

    PubMed  Google Scholar 

  34. Ganesan AN, Shipp NJ, Brooks AG, Kuklik P, Lau DH, Lim HS, et al. Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc. 2013. https://doi.org/10.1161/JAHA.112.004549.

  35. Baman TS, Jongnarangsin K, Chugh A, et al. Prevalence and predictors of complications of radiofrequency catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22:626–31.

    PubMed  PubMed Central  Google Scholar 

  36. Cappato R, Calkins H, Chen S-A, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3:32–8.

    PubMed  Google Scholar 

  37. Neumann T, Vogt J, Schumacher B, et al. Circumferential pulmonary vein isolation with the cryoballoon technique. J Am Coll Cardiol. 2008;52:273–8.

    PubMed  Google Scholar 

  38. Packer DL, Kowal RC, Wheelan KR, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation. J Am Coll Cardiol. 2013;61:1713–23.

    PubMed  Google Scholar 

  39. Guhl EN, Siddoway D, Adelstein E, et al. Incidence and predictors of complications during cryoballoon pulmonary vein isolation for atrial fibrillation. J Am Heart Assoc. 2016. https://doi.org/10.1161/JAHA.116.003724.

  40. Mugnai G, de Asmundis C, Ciconte G, et al. Incidence and characteristics of complications in the setting of second-generation cryoballoon ablation: a large single-center study of 500 consecutive patients. Heart Rhythm. 2015;12:1476–82.

    PubMed  Google Scholar 

  41. Cardoso R, Mendirichaga R, Fernandes G, Healy C, Lambrakos LK, Viles-Gonzalez JF, et al. Cryoballoon versus radiofrequency catheter ablation in atrial fibrillation: a meta-analysis. J Cardiovasc Electrophysiol. 2016;27:1151–9.

    PubMed  Google Scholar 

  42. Di Biase L, Burkhardt JD, Santangeli P, et al. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management. Circulation. 2014;129:2638–44.

    PubMed  Google Scholar 

  43. Hakalahti A, Uusimaa P, Ylitalo K, Raatikainen MJP. Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment. Europace. 2011;13:640–5.

    PubMed  Google Scholar 

  44. Wazni OM, Beheiry S, Fahmy T, et al. Atrial fibrillation ablation in patients with therapeutic international normalized ratio. Circulation. 2007;116:2531–4.

    PubMed  Google Scholar 

  45. Calkins H, Willems S, Gerstenfeld EP, et al. Uninterrupted Dabigatran versus warfarin for ablation in atrial fibrillation. N Engl J Med. 2017;376:1627–36.

    CAS  PubMed  Google Scholar 

  46. Cappato R, Marchlinski FE, Hohnloser SH, et al. Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation. Eur Heart J. 2015;36:1805–11.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Scherr D, Dalal D, Chilukuri K, et al. Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2009;20:379–84.

    PubMed  Google Scholar 

  48. McCready JW, Nunn L, Lambiase PD, Ahsan SY, Segal OR, Rowland E, et al. Incidence of left atrial thrombus prior to atrial fibrillation ablation: is pre-procedural transoesophageal echocardiography mandatory? Europace. 2010;12:927–32.

    PubMed  Google Scholar 

  49. Santangeli P, Zado ES, Hutchinson MD, et al. Prevalence and distribution of focal triggers in persistent and long-standing persistent atrial fibrillation. Heart Rhythm. 2016;13:374–82.

    PubMed  Google Scholar 

  50. Shah D, Haissaguerre M, Jais P, Hocini M. Nonpulmonary vein foci: do they exist? Pacing Clin Electrophysiol. 2003;26:1631–5.

    PubMed  Google Scholar 

  51. Chen S-A, Tai C-T. Catheter ablation of atrial fibrillation originating from the non-pulmonary vein foci. J Cardiovasc Electrophysiol. 2005;16:229–32.

    PubMed  Google Scholar 

  52. Di Biase L, Burkhardt JD, Mohanty P, et al. Left atrial appendage. Circulation. 2010;122:109–18.

    PubMed  Google Scholar 

  53. He X, Zhou Y, Chen Y, Wu L, Huang Y, He J. Left atrial posterior wall isolation reduces the recurrence of atrial fibrillation: a meta-analysis. J Interv Card Electrophysiol. 2016;46:267–74.

    PubMed  Google Scholar 

  54. Tamborero D, Mont L, Berruezo A, et al. Left atrial posterior wall isolation does not improve the outcome of circumferential pulmonary vein ablation for atrial fibrillation. Circ Arrhythm Electrophysiol. 2009;2:35–40.

    PubMed  Google Scholar 

  55. Kim YG, Shim J, Oh S-K, Lee K-N, Choi J-I, Kim Y-H. Electrical isolation of the left atrial appendage increases the risk of ischemic stroke and transient ischemic attack regardless of postisolation flow velocity. Heart Rhythm. 2018;15:1746–53.

    PubMed  Google Scholar 

  56. Cox JL, Boineau JP, Schuessler RB, Ferguson TB, Cain ME, Lindsay BD, et al. Successful surgical treatment of atrial fibrillation. JAMA. 1991;266:1976.

    CAS  PubMed  Google Scholar 

  57. Chiappini B, Martìn-Suàrez S, LoForte A, Arpesella G, Di Bartolomeo R, Marinelli G. Cox/Maze III operation versus radiofrequency ablation for the surgical treatment of atrial fibrillation: a comparative study. Ann Thorac Surg. 2004;77:87–92.

    PubMed  Google Scholar 

  58. •• Badhwar V, Rankin JS, Damiano RJ, et al. The Society of Thoracic Surgeons 2017 Clinical practice guidelines for the surgical treatment of atrial fibrillation. Ann Thorac Surg. 2017;103:329–41 Recent update from the Thoracic Surgeons Society which supports the AF ablation in most surgical interventions. Summarizes research relating to AF ablation and mortality, stroke, and quality of stroke.

    PubMed  Google Scholar 

  59. Kim WK, Kim HJ, Kim JB, Jung S-H, Choo SJ, Chung CH, et al. Concomitant ablation of atrial fibrillation in rheumatic mitral valve surgery. J Thorac Cardiovasc Surg. 2019;157:1519–1528.e5.

    PubMed  Google Scholar 

  60. Ad N, Holmes SD, Rongione AJ, Badhwar V, Wei L, Fornaresio LM, et al. The long-term safety and efficacy of concomitant Cox maze procedures for atrial fibrillation in patients without mitral valve disease. J Thorac Cardiovasc Surg. 2019;157:1505–14.

    PubMed  Google Scholar 

  61. Rankin JS, Grau-Sepulveda MV, Ad N, et al. Associations between surgical ablation and operative mortality after mitral valve procedures. Ann Thorac Surg. 2018;105:1790–6.

    PubMed  Google Scholar 

  62. Damiano RJ, Gaynor SL, Bailey M, Prasad S, Cox JL, Boineau JP, et al. The long-term outcome of patients with coronary disease and atrial fibrillation undergoing the cox maze procedure. J Thorac Cardiovasc Surg. 2003;126:2016–21.

    PubMed  Google Scholar 

  63. Akpinar B, Sanisoglu I, Guden M, Sagbas E, Caynak B, Bayramoglu Z. Combined off-pump coronary artery bypass grafting surgery and ablative therapy for atrial fibrillation: early and mid-term results. Ann Thorac Surg. 2006;81:1332–7.

    PubMed  Google Scholar 

  64. Phan K, **e A, La Meir M, Black D, Yan TD. Surgical ablation for treatment of atrial fibrillation in cardiac surgery: a cumulative meta-analysis of randomised controlled trials. Heart. 2014;100:722–30.

    PubMed  Google Scholar 

  65. Barnett SD, Ad N. Surgical ablation as treatment for the elimination of atrial fibrillation: a meta-analysis. J Thorac Cardiovasc Surg. 2006;131:1029–35.

    PubMed  Google Scholar 

  66. Budera P, Straka Z, Osmancik P, et al. Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study. Eur Heart J. 2012;33:2644–52.

    PubMed  PubMed Central  Google Scholar 

  67. Suwalski P, Kowalewski M, Jasiński M, et al. Survival after surgical ablation for atrial fibrillation in mitral valve surgery: analysis from the Polish National Registry of Cardiac Surgery Procedures (KROK). J Thorac Cardiovasc Surg. 2019;157:1007–18 e4.

  68. • Iribarne A, DiScipio AW, McCullough JN, et al. Surgical atrial fibrillation ablation improves long-term survival: a multicenter analysis. Ann Thorac Surg. 2019;107:135–42 Retrospective multicenter analysis of >20,000 patients that addresses the issue of mortality benefit for surgical ablation in AF. Suggests that surgical ablation improves mortality.

    PubMed  Google Scholar 

  69. Ad N, Holmes SD, Friehling T. Minimally invasive stand-alone cox maze procedure for persistent and long-standing persistent atrial fibrillation. Circ Arrhythm Electrophysiol. 2017. https://doi.org/10.1161/CIRCEP.117.005352.

  70. Pasic M, Musci M, Siniawski H, Grauhan O, Edelmann B, Tedoriya T, et al. The cox maze III procedure: parallel normalization of sinus node dysfunction, improvement of atrial function, and recovery of the cardiac autonomic nervous system. J Thorac Cardiovasc Surg. 1999;118:287–96.

    CAS  PubMed  Google Scholar 

  71. Gammie JS, Haddad M, Milford-Beland S, Welke KF, Ferguson TB, O’Brien SM, et al. Atrial fibrillation correction surgery: lessons from the society of thoracic surgeons national cardiac database. Ann Thorac Surg. 2008;85:909–14.

    PubMed  Google Scholar 

  72. Buber J, Luria D, Sternik L, et al. Left atrial contractile function following a successful modified maze procedure at surgery and the risk for subsequent thromboembolic stroke. J Am Coll Cardiol. 2011;58:1614–21.

    PubMed  Google Scholar 

  73. Rankin JS. Amiodarone and cardiac surgery. J Thorac Cardiovasc Surg. 2007;134:271.

    PubMed  Google Scholar 

  74. Ad N, Holmes SD, Shuman DJ, Pritchard G, Miller CE. Amiodarone after surgical ablation for atrial fibrillation: is it really necessary? A prospective randomized controlled trial. J Thorac Cardiovasc Surg. 2016;151:798–803.

    CAS  PubMed  Google Scholar 

  75. Kiser AC, Landers M, Horton R, Hume A, Natale A, Gersak B. The convergent procedure: a multidisciplinary atrial fibrillation treatment. Heart Surg Forum. 2010;13:E317–21.

    PubMed  Google Scholar 

  76. Honarbakhsh S, Birch S, Baker V, O’Brien B, Lowe M, Hunter R, et al. Radiofrequency balloon catheter ablation for paroxysmal atrial fibrillation, radiance study—a UK experience. EP Eur. 2017;19:i21.

    Google Scholar 

  77. Wojtaszczyk A, Caluori G, Pešl M, Melajova K, Stárek Z. Irreversible electroporation ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2018;29:643–51.

    PubMed  Google Scholar 

  78. Wittkampf FHM, van Es R, Neven K. Electroporation and its relevance for cardiac catheter ablation. JACC Clin Electrophysiol. 2018;4:977–86.

    PubMed  Google Scholar 

  79. Reddy VY, Neuzil P, Koruth JS, Petru J, Funosako M, Cochet H, Sediva L, Chovanec M, Dukkipati SR, Jais P (2019) Pulsed field ablation for pulmonary vein isolation in atrial fibrillation. J Am Coll Cardiol 26225.

  80. DeSimone CV, Kapa S, Asirvatham SJ. Electroporation: past and future of catheter ablation. Circ Arrhythm Electrophysiol. 2014;7:573–5.

    PubMed  PubMed Central  Google Scholar 

  81. von Oppell UO, Masani N, O’Callaghan P, Wheeler R, Dimitrakakis G, Schiffelers S. Mitral valve surgery plus concomitant atrial fibrillation ablation is superior to mitral valve surgery alone with an intensive rhythm control strategy. Eur J Cardio-Thoracic Surg. 2009;35:641–50.

    Google Scholar 

  82. Jessurun ER, van Hemel NM, Defauw JJ, Brutel De La Rivière A, Stofmeel MAM, Kelder JC, et al. A randomized study of combining maze surgery for atrial fibrillation with mitral valve surgery. J Cardiovasc Surg. 2003;44:9–18.

    CAS  Google Scholar 

  83. Verma A, Ha ACT, Kirchhof P, et al. The optimal anti-coagulation for enhanced-risk patients post–catheter ablation for atrial fibrillation (OCEAN) trial. Am Heart J. 2018;197:124–32.

    CAS  PubMed  Google Scholar 

  84. Huxley RR, Lopez FL, Folsom AR, Agarwal SK, Loehr LR, Soliman EZ, et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2011;123:1501–8.

    PubMed  PubMed Central  Google Scholar 

  85. Munger TM, Dong Y-X, Masaki M, et al. Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation. J Am Coll Cardiol. 2012;60:851–60.

    PubMed  Google Scholar 

  86. Holmqvist F, Guan N, Zhu Z, et al. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation—results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2015;169:647–654.e2.

    PubMed  Google Scholar 

  87. Trembley-Gravel M, White M, Roy D, et al. Blood pressure and atrial fibrillation: a combined AF-CHF and AFFIRM analysis. J Cardiovasc Electrophysiol. 2015;26:509–14.

    Google Scholar 

  88. Huxley RR, Alonso A, Lopez FL, Filion KB, Agarwal SK, Loehr LR, et al. Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study. Heart. 2012;98:133–8.

    CAS  PubMed  Google Scholar 

  89. Ettinger PO, Wu CF, De La Cruz C, Weisse AB, Ahmed SS, Regan TJ. Arrhythmias and the “Holiday Heart”: alcohol-associated cardiac rhythm disorders. Am Heart J. 1978;95:555–62.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Section on Cardiovascular Medicine, Wake Forest University Baptist Medical Center, 1 Medical Center Boulevard, Winston-Salem, NC, 27157, USA

    Neel J. Patel MD, Joan A. Maradey MD & Prashant D. Bhave MD, FHRS

Authors
  1. Neel J. Patel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joan A. Maradey MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prashant D. Bhave MD, FHRS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Prashant D. Bhave MD, FHRS.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Arrhythmia

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Patel, N.J., Maradey, J.A. & Bhave, P.D. Atrial Fibrillation Ablation: Indications and Techniques. Curr Treat Options Cardio Med 21, 43 (2019). https://doi.org/10.1007/s11936-019-0747-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11936-019-0747-y

Keywords

Search

Navigation